Particle.news
Download on the App Store

Michael McIntyre Reveals He Is Using Mounjaro After Obesity Diagnosis

The disclosure spotlights the surge in GLP‑1 weight‑loss drugs originally developed for diabetes.

Overview

  • The comedian told a London audience he weighed 100kg (15st 10lbs) and that his GP used the medical term "obese."
  • He said he first tried Ozempic before switching to Mounjaro and began noticing weight loss in about three weeks.
  • McIntyre described initial reluctance but said his wife, Kitty, pushed him to start the injections.
  • Reports describe Mounjaro (tirzepatide) as a GLP‑1‑type drug developed for diabetes that curbs appetite and is now widely used for weight loss, including by high‑profile figures.
  • Coverage sets his decision against NHS guidance that classifies most adults with a BMI of 30–39.9 as medically obese and notes the details come from his on‑stage remarks.